JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koepfli, P.
Right arrow Articles by Kaufmann, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koepfli, P.
Right arrow Articles by Kaufmann, P. A.
Journal of Nuclear Medicine Vol. 45 No. 10 1626-1631
© 2004 by Society of Nuclear Medicine


Clinical Investigations

ß-Adrenergic Blockade and Myocardial Perfusion in Coronary Artery Disease: Differential Effects in Stenotic Versus Remote Myocardial Segments

Pascal Koepfli, MD1, Christophe A. Wyss, MD1, Mehdi Namdar, MD1, Michael Klainguti, MD1, Gustav K. von Schulthess, MD, PhD2, Thomas F. Lüscher, MD3 and Philipp A. Kaufmann, MD1

1 Nuclear Cardiology Section, University Hospital, Zurich, Switzerland
2 Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
3 Division of Cardiology, University Hospital, Zurich, Switzerland

ß-Adrenergic blocking agents are widely used in coronary artery disease (CAD), although their impact on myocardial blood flow (MBF) and coronary flow reserve (CFR) remains unclear. We studied the effect of long-term ß-blocker treatment (carvedilol or metoprolol) on coronary microcirculation in CAD patients using PET. Methods: Regional and global resting and adenosine-induced hyperemic MBF and CFR were measured with 13N-ammonia and PET in 36 CAD patients before and after 12 wk of oral therapy with either carvedilol, 50 mg/d, or metoprolol, 100 mg/d. Results: ß-Blockade decreased global resting MBF in proportion to cardiac work (from 0.86 ± 0.20 to 0.77 ± 0.14 mL/min/g, P < 0.05) without affecting global hyperemic flow. Hyperemic MBF was significantly lower in stenosis-dependent segments than in remote segments (1.76 ± 0.64 vs. 2.04 ± 0.67 mL/min/g, P < 0.05) at baseline but was comparable in both after treatment (2.02 ± 0.68 vs. 1.90 ± 0.78 mL/min/g, P = not statistically significant [NS]), resulting in a significant CFR increase in stenotic segments (+15%, P < 0.05) but not in remote segments (+9%, P = NS). Conclusion: The beneficial effect of ß-adrenergic blockade can be explained by the reduction in oxygen consumption (= decreased demand) but also by a modest improvement in vasodilator capacity (= increased supply). The improvement in CFR is found predominantly in stenosis-dependent rather than remote segments.

Key Words: ß-adrenergic blockade • coronary artery disease • myocardial blood flow • PET


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
G. J. Zoghbi, T. A. Dorfman, and A. E. Iskandrian
The Effects of Medications on Myocardial Perfusion
J. Am. Coll. Cardiol., August 5, 2008; 52(6): 401 - 416.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Schepis, O. Gaemperli, V. Treyer, I. Valenta, C. Burger, P. Koepfli, M. Namdar, I. Adachi, H. Alkadhi, and P. A. Kaufmann
Absolute Quantification of Myocardial Blood Flow with 13N-Ammonia and 3-Dimensional PET
J. Nucl. Med., November 1, 2007; 48(11): 1783 - 1789.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. T. George, C. Silva, M. A.S. Cordeiro, A. DiPaula, D. R. Thompson, W. F. McCarthy, T. Ichihara, J. A.C. Lima, and A. C. Lardo
Multidetector Computed Tomography Myocardial Perfusion Imaging During Adenosine Stress
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, R. Harkonen, M. Luotolahti, R. Borra, J. Sundell, J. Knuuti, and P. Nuutila
Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery Disease
Diabetes, February 1, 2006; 55(2): 511 - 516.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.